Heart Disease Clinical Trials in New York

Showing 441-460 of 507 trials

Catheter Ablation for Atrial Fibrillation and Heart Failure

NCT01082601

To compare heart function, symptoms, exercise capacity and quality of life in patients with Congestive Heart Failure (CHF) and Atrial Fibrillation (AF)before and after catheter ablation. Hypothesis: Restoration and maintenance of sinus rhythm by catheter ablation, without the use of antiarrhythmic drugs, in AF and CHF improves heart failure status.

Congestive Heart FailureAtrial FibrillationArrhythmia

St. Luke's-Roosevelt Hospital CenterStarted Apr 2010

Ridgewood, New Jersey, United States • New York, New York, United States

COMPLETEDNA< 1 mile

Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf)

NCT00354159

The purpose of this clinical research study is to evaluate the safety and effectiveness of the investigational implantable hemodynamic monitor (IHM), and of the IHM in combination with an implantable cardioverter defibrillator (ICD). The investigational IHM has the ability to record and report the force with which the heart pumps blood (heart pressures). When combined with the ICD, the device has the additional ability to send a strong electrical impulse, or shock, to the heart when it detects dangerously fast heartbeats to return it to a normal rhythm. The IHM and IHM/ICD are implanted surgically just under the skin in the upper chest area. This study will also determine how doctors use the information related to heart pressures in the management of heart failure.

Heart Failure

Medtronic Cardiac Rhythm and Heart Failure442 participantsStarted Apr 2006

Birmingham, Alabama, United States • La Jolla, California, United States • Loma Linda, California, United States +49 more locations

Catheter Ablation for Atrial Fibrillation and Heart Failure

Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf)

Heart Disease Trials in Other Cities

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions

Saphenous Vein Allografts for Coronary Bypass

Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests

The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices

The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?

Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure

Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure

Physiological Response to Exercise: Sensor Evaluation at Specified Exertions

Attain Success Clinical Trial

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)

Additional KIF6 Risk Offers Better Adherence to Statins

A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin

A-priori Versus Provisional Heparin on Radial Artery Occlusion After Transradial Coronary Angiography and Patent Hemostasis

Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions

Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease

Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease

Other Conditions in New York